Navigation Links
Altitude Research Center wins major Pentagon grants
Date:3/28/2011

AURORA (March 28, 2011) As the American military rushes to confront adversaries in some of the world's highest mountain ranges, the Department of Defense is giving $4 million to the Altitude Research Center at the University of Colorado School of Medicine to develop revolutionary ways to combat high altitude sickness in soldiers, sailors and marines.

The Altitude Research Center, the only civilian institution focused on studying the effects of altitude on human physiology, received two grants as part of a Pentagon's increased emphasis on using biology to create better fighting men and women. Specifically, the government wants to find ways to swiftly overcome Acute Mountain Sickness or AMS which often strikes those serving in Afghanistan.

One grant for $2.5 million will allow scientists to create an easy-to-use test kit to determine who is likely to get altitude sickness before they are deployed. A second $1.5 million grant will fund research seeking to find the basic molecular processes behind acclimatization with the hope of discovering new ways to protect armed forces personnel from high altitude illness. At the same time, the study could have major implications for medical research, specifically the role altitude plays in cancer, heart and lung disease.

"We believe the immediate impact of these studies will be to save lives and improve the performance of those fighting at high altitude," said Robert Roach, PhD, director of the Altitude Research Center. "But in the long term, we hope it will lead to new discoveries that can benefit those who suffer from low oxygen states, whether they live and work at high altitude or have heart, lung or other diseases at any altitude."

AMS can cause dizziness, excessive thirst, fatigue, nausea, sleeplessness and swelling of the brain.

"Right now we have no reliable way to predict who will get AMS and who will remain healthy at high altitude," Roach said. "This is a major concer
'/>"/>

Contact: David Kelly
david.kelly@ucdenver.edu
303-315-6374
University of Colorado Denver
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UCSD researchers make first direct observations of biological particles in high-altitude ice clouds
2. Babies born to native high-altitude mothers have decreased risk of low birth weight
3. Winter Olympics: Altitude affects skill sports, not just endurance events
4. High-altitude research advances low-altitude medicine
5. Fruit flies use horizontal landmarks for altitude control, says Caltech research team
6. Tennis stars hospitalization for altitude sickness
7. Study shows living at high altitude reduces risk of dying from heart disease
8. Wistar Institute researcher receives New Innovator award from NIH
9. NC State researchers get to root of parasite genome
10. White Mountain Research Station to host climate change conference
11. Stevens awarded $1M for advanced biofuels research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... OXFORD, Conn. , July 7, 2015 NXT-ID, Inc. ... company focused on the growing mobile commerce market announces a revised ... airing this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the ...
(Date:6/30/2015)... -- Genisphere announced Tom Bliss ... develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss comes ... of the last 25 years in leadership positions at ... & Johnson. Tom started his career in Investment Banking, ... He graduated from Dartmouth College with a BA in ...
(Date:6/25/2015)... 25, 2015  TAKE Solutions Ltd., a global business ... United States Patent and Trademark Office (USPTO) for its ... TAKE Solutions, Clinical Accelerators to reduce the time taken ... to standardization without the accelerators), thus reducing time to ... At the heart of the patented Clinical Data ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3TAKE Solutions Awarded Patent By USPTO 2
... the fields of social, biological and medical science will ... discuss how they can cooperate to improve our understanding ... how our genetic inheritance is expressed (epigenetics). This collaboration ... changes have for such key social policy issues as ...
... pharmaceutical companies and four research institutions, working with the ... partnership that aims to speed the discovery of essential ... known as the TB Drug Accelerator (TBDA), will target ... early-stage research. The long-term goal of the TBDA is ...
... is home to a teeming ecosystem of microbes that is ... while the gut microbiota is interacting with our body, they ... study published online in Genome Research , ... set of viruses associated with gut microbiota in global populations. ...
Cached Biology News:World experts meet in Edinburgh to consider how life experiences impact on our genes 27 pharmaceutical companies join academic researchers to speed TB drug discovery 2Gut microbes battle a common set of viruses shared by global populations 2
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards Company, ... / linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin ... using the CLSI recommended “equal delta” method for linearity testing and is liquid, ...
(Date:7/24/2015)... Pa. , July 24, 2015 Ryan ... been filed in United States District Court for the Northern ... all persons or entities that purchased the common stock of ... ) between July 31, 2014 and June 15, 2015, inclusive ... than September 8, 2015, move the Court for appointment as ...
(Date:7/24/2015)... July 24, 2015 Equity Research ... BioPharma Inc. (NASDAQ: PDLI ), Arena Pharmaceuticals Inc. ... ), Northwest Biotherapeutics Inc. (NASDAQ: NWBO ), and ... report on PDL BioPharma can be accessed at ... Composite ended at 5,146.41, down 0.49%, the Dow Jones ...
(Date:7/24/2015)... Orexigen Therapeutics, Inc. (Nasdaq: OREX ) ... quarter 2015 on Thursday, August 6 before the market ... update and discuss the financial results in a live ... (5:00 a.m. Pacific Time). The live call ... (domestic) or (847) 413-3238 (international), participant code 40327229. The ...
Breaking Biology Technology:Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... ( http://www.amdl.com ),AMDL, Inc. (Amex: ADL ), ... China and the US, today announced that the,Company will ... New,York City on Tuesday, October 7, 2008 at 10:30 ... Hyatt New York Hotel in the Morosco Room., ...
... Proceeds to Support R&D Efforts and Clinical ... BETHESDA, Md., Oct. 3 Micromet, Inc. ... company developing,novel, proprietary antibodies for the treatment ... that it has closed its previously,announced $40 ...
... of Aberdeen and Rothamsted Research for releasing natural insect repellents that ... technology is set to revolutionise how people protect buildings from unwanted ... ... (PRWEB) October 3, 2008 -- Atrium Innovation Ltd has developed a ...
Cached Biology Technology:AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 2AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008 3Micromet Closes $40 Million Private Equity Placement 2Micromet Closes $40 Million Private Equity Placement 3Micromet Closes $40 Million Private Equity Placement 4New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 2New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 3New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS 4
...
... Clone/PAD: 3B8A10. ... to the C-terminal region ... Specificity: Specific for the ... Reactivity: Human (positive control: ...
Negative Control, eluted and packaged aseptically in 20l of 10mM Tris-HCL, pH 8.0, 1 mM EDTA, 5 years at either 4°C or -20°C...
...
Biology Products: